Crystalline 3-{4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile citrate

  • US 6,965,027 B2
  • Filed: 12/04/2002
  • Issued: 11/15/2005
  • Est. Priority Date: 12/06/2001
  • Status: Active Grant
First Claim
Patent Images

1. A crystalline form of 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl}-3-oxo-propionitrile mono citrate salt.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×